Multiple myeloma is considered incurable, but a third of patients in a Johnson & Johnson clinical trial have lived without ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care ...

Population model successfully developed to characterize BI-1910 pharmacokinetics and pharmacodynamics across a broad range of ...

Discover the major highlights from ASCO 2025, according to researchers and drug developers who attended the convention.

An colon cancer study highlighted the importance of the National Cancer Institute, while cancer doctors got a look at a bispecific antibody newly licensed by Pfizer.

University of South Florida and Tampa General Hospital Cancer Institute launch the “Microbial Oncogenesis and Cancer Therapy” ...

The strategic collaboration includes an exchange of Agenus' state-of-the-art biologics CMC facilities in Emeryville, CA and Berkeley, CA for upfront consideration of $75M; Agenus to receive up to an ...

Katie Lakofsky, bioscience workforce director for UD and the Delaware Bioscience Association, is focused on building the ...

Fintel reports that on June 4, 2025, HC Wainwright & Co. upgraded their outlook for Agenus (NasdaqCM:AGEN) from Neutral to ...

Zydus Lifesciences Ltd enters global biologics CDMO market with acquisition of Agenus Inc.'s manufacturing facilities in the ...